News US authorities probe marketing of J&J drugs US authorities suspicious over marketing, rebates and payment support programmes.
News EU regulators back two more orphan drugs, question of pricin... Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.
News J&J's Remicade faces further biosimilar competition in US FDA approves Samsung Bioepis biosimilar.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
News After healthcare defeat, markets fear Trump's tax plans will... Trump could use executive powers to undermine system.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
